RL
Rajiv Lochan Sahu
About Rajiv Lochan Sahu
Data last updated:
Rajiv Lochan Sahu is a Director at Vidacrest Lifescience Private Limited (since 2019). The companies operate in Chemicals and Pharma. Vidacrest Lifescience Private Limited reported revenue of ₹51.1 Lakh (FY 2024). Earlier, Rajiv Lochan Sahu was a Director at Latin Pharma Services India Private Limited (2014–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jul 2019 | 2019 | ₹51.1 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Nov 2014 | 2012 | ₹3.1 Lakh (FY 2021) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajiv Lochan Sahu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akshaya Kumar Behera | 08501691 | Vidacrest Lifescience Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Lochan Sahu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Lochan Sahu
Rajiv Lochan Sahu currently holds 1 directorship: Vidacrest Lifescience Private Limited (Director, since 05 Jul 2019, revenue ₹51.1 Lakh (FY 2024)).
Rajiv Lochan Sahu was first appointed on 03 Nov 2014 as Director at Latin Pharma Services India Private Limited. The most recent appointment on record is 05 Jul 2019 at Vidacrest Lifescience Private Limited.
Rajiv Lochan Sahu held 1 earlier board appointment: Latin Pharma Services India Private Limited (Director, 03 Nov 2014 to 31 Jan 2016).
The current boards of Rajiv Lochan Sahu's companies include Akshaya Kumar Behera (Vidacrest Lifescience Private Limited).